Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
CERo Therapeutics Holdings, Inc. (CERO) had Operating Cash Flow per Share of $-9.70 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-11.51M |
|
-- |
|
-- |
|
$4.36M |
|
$-4.36M |
|
$-0.49M |
|
$-4.86M |
|
$-4.86M |
|
$-4.86M |
|
$-4.86M |
|
$-4.86M |
|
$-4.86M |
|
$-4.36M |
|
$-4.09M |
|
1.26M |
|
1.26M |
|
$-9.10 |
|
$-9.10 |
|
| Balance Sheet Financials | |
$2.55M |
|
$0.31M |
|
$1.36M |
|
$3.91M |
|
$8.45M |
|
-- |
|
-- |
|
$8.45M |
|
$-13.24M |
|
$-4.54M |
|
$-4.54M |
|
1.50M |
|
| Cash Flow Statement Financials | |
$-12.27M |
|
$0.50M |
|
$10.47M |
|
$3.33M |
|
$2.02M |
|
$-1.30M |
|
$1.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
36.68% |
|
106.89% |
|
-124.16% |
|
106.89% |
|
$-3.04 |
|
$-9.31 |
|
|
Operating Cash Flow per Share |
$-9.70 |